Drug companies routinely make hidden pacts with middlemen. This is a Kaiser Health News story. Lisa Crook was lucky. She saved $800 last year after her insurance company started covering a new, less ...

Lisa Crook was lucky. She saved $800 last year after her insurance company started covering a new, less expensive insulin called Basaglar that was virtually identical to the brand she had used for ...

A new form of insulin just hit American markets. Basaglar was approved in December 2015, but had to wait a year before launching on Thursday. A spokeswoman for Eli Lilly, the company that makes ...

Medicare Part D may cover Basaglar, a long-acting insulin, and under the Inflation Reduction Act, the cost should not exceed $35 per month. The availability of Basaglar under Medicare Part D depends ...

The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup. The first “follow-on” insulin for diabetics, similar to a generic medication for synthetic ...

In 2015, only 19 percent of generic drugs covered by Medicare were in the preferred formulary tiers with the lowest out-of-pocket costs, found a study last year by consultants Avalere. In 2011, on the ...

Original Medicare (Part A and Part B) does not cover insulin glargine (Basagalar). Medicare Part C and Part D cover some forms of insulin if you have diabetes, but coverage depends on the plan‘s ...